|
시장보고서
상품코드
1423999
세계 허드론 요법 시장 : 점유율, 시장 규모, 동향, 산업 분석 보고서 - 유형별, 용도별, 최종 사용자별, 지역별, 부문별 예측(2024년-2032년)Hadron Therapy Market Share, Size, Trends, Industry Analysis Report, By Type (Electron Beam, Proton Beam, Neutron Beam, Carbon Ion Beam, Alpha Particle Beam, and Beta Particle Beam); By Application; By End User; By Region; Segment Forecast, 2024-2032 |
||||||
Polaris Market Research의 최신 조사에 따르면 세계 허드론 요법 시장 규모는 2032년까지 47억 2,000만 달러에 달할 전망입니다. 이 보고서는 현재 시장 역학을 상세하게 인사이트하고 미래 시장 성장에 대한 분석을 제공합니다.
세계 암의 유병률 증가, 기술 진보의 진전에 의한 치료 기간의 단축, 하드론 요법의 잠재적인 유용성을 인식하고, 새로운 센터의 설립에 재정적 지원을 제공하는 정부 증가 등이 시장의 성장에 영향을 미치는 두드러진 요인이되었습니다. 게다가 개선된 치료 옵션의 중요성과 가용성에 대한 건강관리 전문가와 일반 시민들의 의식 증가, 교육 이니셔티브 및 교육 프로그램의 성장은 시장에 큰 성장 기회를 가져올 것으로 예측됩니다.
예를 들어(2023년) 7월, Apollo Hospitals사는 인도의 각지에 암을 위한 양자선 치료 센터를 2개소 신설할 계획을 발표했습니다. 이 확장 계획을 통해 회사는 국내의 다양한 지역에서 시장을 확장하고 암 및 기타 관련 문제로 고통받는 보다 광범위한 환자층을 수용할 수 있습니다.
최근, 기업은 양성자선이나 탄소 이온빔의 조사를 최적화하는 복잡한 알고리즘을 이용한 첨단 치료 계획 소프트웨어의 도입이나 건강한 조직에의 데미지를 최소화하면서 치료 효과를 극대화 개인화 치료 계획 개발에 중점을 두고 있으며, 가까운 미래에이 시장은 크게 성장할 가능성이 있습니다.
이와는 별도로, 개선된 치료 전달 시스템, 영상 유도 기술, 적응 요법 등의 기술적 측면에서의 지속적인 진보는 전반적인 치료 정확성과 효능을 강화할 수 있는 유리한 기회를 제공하며, 하드론 요법 을 이전의 치료법과 비교하여 더욱 매력적이고 효과적인 것으로 만드는 것은 수년 동안 큰 시장 성장을 가져올 것입니다.
허드론 치료 시장 보고서 하이라이트
알파 입자 라인 부문은 많은 유익한 특성과 암 환자 사이의 인지도 증가로 주목할만한 점유율을 차지했습니다.
소아암 부문은 주로 세계 소아암 환자 증가로 시장 점유율의 대부분을 차지했습니다.
병원 부문은 큰 점유율을 차지하며 업계를 선도합니다. 이는 병원에서 이러한 치료를 위한 첨단 또는 혁신적인 장비를 쉽게 이용할 수 있다는 배경입니다.
북미는 의료 인프라에 대한 지출이 증가하고 인지도가 높아짐에 따라 2022년 시장을 독점했습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계 허드론 요법 시장 인사이트
- 허드론 요법 시장 - 용도의 스냅샷
- 허드론 요법 시장 역학
- 성장 촉진요인과 기회
- 암 발생률 증가와 상환 정책 개선이 시장 성장을 가속
- 기술과 치료법의 진보
- 억제요인과 과제
- 제한된 임상 증거와 비교 연구
- 성장 촉진요인과 기회
- PESTEL 분석
- 허드론 요법 시장 응용 동향
- 밸류체인 분석
- COVID-19 감염의 영향 분석
제5장 세계 허드론 요법 시장 - 유형별
- 주요 조사 결과
- 소개
- 전자선
- 양자선
- 뉴런 빔
- 탄소 이온 빔
- 알파 입자선
- 베타 입자선
제6장 세계 허드론 요법 시장 - 최종 사용자별
- 주요 조사 결과
- 소개
- 병원
- 국립대학
- 연구기관
제7장 세계 허드론 요법 시장 - 용도별
- 주요 조사 결과
- 소개
- 소아암
- 뼈?연부암
- 전립선암
- 폐암
- 간암
- 눈암
- 두경부암
제8장 세계 허드론 요법 시장 - 지역별
- 주요 조사 결과
- 소개
- 허드론 요법 시장 평가, 지역별(2019년-2032년)
- 허드론 요법 시장 - 북미
- 북미 : 하드론 요법 시장 - 유형별(2019년-2032년)
- 북미 : 하드론 요법 시장 - 용도별(2019년-2032년)
- 북미 : 하드론 요법 시장 - 최종 사용자별(2019년-2032년)
- 허드론 요법 시장 - 미국
- 허드론 요법 시장 - 캐나다
- 허드론 요법 시장 - 유럽
- 유럽 : 하드론 요법 시장 - 유형별(2019년-2032년)
- 유럽 : 하드론 요법 시장 - 용도별(2019년-2032년)
- 유럽 : 하드론 요법 시장 - 최종사용자별(2019년-2032년)
- 허드론 요법 시장 - 영국
- 허드론 요법 시장 - 프랑스
- 허드론 요법 시장 - 독일
- 허드론 요법 시장 - 이탈리아
- 허드론 요법 시장 - 스페인
- 허드론 요법 시장 - 네덜란드
- 허드론 요법 시장 - 러시아
- 허드론 요법 시장 - 아시아태평양
- 아시아태평양 : 하드론 요법 시장 - 유형별(2019년-2032년)
- 아시아태평양 : 하드론 요법 시장 - 용도별(2019년-2032년)
- 아시아태평양 : 하드론 요법 시장 - 최종 사용자별(2019년-2032년)
- 허드론 요법 시장 - 중국
- 허드론 요법 시장 - 인도
- 허드론 요법 시장 - 말레이시아
- 허드론 요법 시장 - 일본
- 허드론 요법 시장 - 인도네시아
- 허드론 요법 시장 - 한국
- 허드론 요법 시장 - 중동 및 아프리카
- 중동 및 아프리카 : 하드론 요법 시장 - 유형별(2019년-2032년)
- 중동 및 아프리카 : 하드론 요법 시장 - 용도별(2019년-2032년)
- 중동 및 아프리카 : 하드론 요법 시장 - 최종 사용자별(2019년-2032년)
- Hadron 치료 시장 - 사우디아라비아
- 허드론 요법 시장 - 아랍에미리트(UAE)
- 허드론 요법 시장 - 이스라엘
- 허드론 요법 시장 - 남아프리카
- 허드론 요법 시장 - 라틴아메리카
- 라틴아메리카 : 하드론 요법 시장 - 유형별(2019년-2032년)
- 라틴아메리카 : 하드론 요법 시장 - 용도별(2019년-2032년)
- 라틴아메리카 : 하드론 요법 시장 - 최종 사용자별(2019년-2032년)
- 허드론 요법 시장 - 멕시코
- 허드론 요법 시장 - 브라질
- 허드론 요법 시장 - 아르헨티나
제9장 경쟁 구도
- 확장 및 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 프로파일
- Advanced Oncotherapy
- .Danfysik A/S
- Elekta
- Hitachi Ltd
- IBA Worldwide
- Koninklijke Philips NV
- Mevion Medical Systems
- Mitsubishi Electric Corporation
- Optivus Proton Therapy Inc.
- ProNova Solutions LLC
- ProTom International
- Provision Healthcare
- Sumitomo Corporation
- Varian Medical Systems Inc
The global hadron therapy market size is expected to reach USD 4.72 billion by 2032, according to a new study by Polaris Market Research. The report "Hadron Therapy Market Share, Size, Trends, Industry Analysis Report, By Type (Electron Beam, Proton Beam, Neutron Beam, Carbon Ion Beam, Alpha Particle Beam, and Beta Particle Beam); By Application; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The increasing prevalence of cancer globally, growing technological advancements reducing the overall duration of treatment, and a growing number of governments recognizing the potential benefits of hadron therapy and providing financial support for the establishment of new centers are among the prominent factors influencing the growth of the market. Additionally, the increased awareness among healthcare professionals and the public about the importance and availability of improved treatment options and growing educational initiatives and training programs are further anticipated to create significant growth opportunities for the market.
For instance, in July 2023, Apollo Hospitals announced its plan to add two new proton therapy centers for cancer in different parts of India. This expansion plan will allow the company to expand its market across various regions of the country and cater to a wider patient pool suffering from cancer and other related issues.
In recent years, companies have extensively focused on the incorporation of advanced treatment planning software that uses complex algorithms to optimize the delivery of proton and carbon-ion beams along with the development of personalized treatment plans that maximize the therapeutic effect while minimizing damage to healthy tissues, which in turn, generating huge growth potential for the market in the near future.
Apart from this, continuous advancements in terms of technology, such as improved treatment delivery systems, image-guided techniques, and adaptive therapy, provide lucrative opportunities to enhance overall treatment precision and efficacy and make hadron therapy even more attractive and effective as compared to previous therapies, will lead to significant market growth over the years.
Hadron Therapy Market Report Highlights
Alpha particle beam segment accounted for a notable share, on account of its numerous beneficial characteristics and growing awareness among patients with cancer
The pediatric cancer segment held the majority market share, mainly due to rising incidences of pediatric cancer worldwide
The hospitals segment led the industry market with a substantial share, which is driven by the easy availability of advanced or innovative equipment for such therapies in hospitals
North America dominated the global market in 2022, owing to the region's increased expenditure on healthcare infrastructure and greater awareness
The key market players include Mevion Medical Systems, Optivus Proton Therapy, Provision Healthcare, Sumitomo Corporation, and Varian Medical Systems
Polaris Market Research has segmented the hadron therapy market report based on type, application, end user, and region:
Hadron Therapy, Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Electron Beam
- Proton Beam
- Neutron Beam
- Carbon Ion Beam
- Alpha Particle Beam
- Beta Particle Beam
Hadron Therapy, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Pediatric Cancer
- Bone & Soft Tissue Cancer
- Prostate Cancer
- Lung Cancer
- Liver Cancer
- Eye Cancer
- Head & Neck Cancer
Hadron Therapy, End User Outlook (Revenue - USD Billion, 2019 - 2032)
- Hospitals
- Government Universities
- Research Institutions
Hadron Therapy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Hadron Therapy Market Insights
- 4.1. Hadron Therapy Market - Application Snapshot
- 4.2. Hadron Therapy Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing incidences of cancer cases and improvements in reimbursement policies boost the market growth
- 4.2.1.2. Advancements in technology and treatment modalities
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Limited clinical evidence and comparative studies
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Hadron Therapy Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Hadron Therapy Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 5.3. Electron Beam
- 5.3.1. Global Hadron Therapy Market, by Electron Beam, by Region, 2019-2032 (USD Billion)
- 5.4. Proton Beam
- 5.4.1. Global Hadron Therapy Market, by Proton Beam, by Region, 2019-2032 (USD Billion)
- 5.5. Neuron Beam
- 5.5.1. Global Hadron Therapy Market, by Neuron Beam, by Region, 2019-2032 (USD Billion)
- 5.6. Carbon Ion Beam
- 5.6.1. Global Hadron Therapy Market, by Carbon Ion Beam, by Region, 2019-2032 (USD Billion)
- 5.7. Alpha Particle Beam
- 5.7.1. Global Hadron Therapy Market, by Alpha Particle Beam, by Region, 2019-2032 (USD Billion)
- 5.8. Beta Particle Beam
- 5.8.1. Global Hadron Therapy Market, by Beta Particle Beam, by Region, 2019-2032 (USD Billion)
6. Global Hadron Therapy Market, by End User
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 6.3. Hospitals
- 6.3.1. Global Hadron Therapy Market, by Hospitals, by Region, 2019-2032 (USD Billion)
- 6.4. Government Universities
- 6.4.1. Global Hadron Therapy Market, by Government Universities, by Region, 2019-2032 (USD Billion)
- 6.5. Research Institutions
- 6.5.1. Global Hadron Therapy Market, by Research Institutions, by Region, 2019-2032 (USD Billion)
7. Global Hadron Therapy Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 7.3. Pediatric Cancer
- 7.3.1. Global Hadron Therapy Market, by Pediatric Cancer, By Region, 2019-2032 (USD Billion)
- 7.4. Bone & Soft Tissue Cancer
- 7.4.1. Global Hadron Therapy Market, by Bone & Soft Tissue Cancer, By Region, 2019-2032 (USD Billion)
- 7.5. Prostate Cancer
- 7.5.1. Global Hadron Therapy Market, by Prostate Cancer, By Region, 2019-2032 (USD Billion)
- 7.6. Lung Cancer
- 7.6.1. Global Hadron Therapy Market, by Lung Cancer, By Region, 2019-2032 (USD Billion)
- 7.7. Liver Cancer
- 7.7.1. Global Hadron Therapy Market, by Liver Cancer, By Region, 2019-2032 (USD Billion)
- 7.8. Eye Cancer
- 7.8.1. Global Hadron Therapy Market, by Eye Cancer, By Region, 2019-2032 (USD Billion)
- 7.9. Head & Neck Cancer
- 7.9.1. Global Hadron Therapy Market, by Head & Neck Cancer, By Region, 2019-2032 (USD Billion)
8. Global Hadron Therapy Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Hadron Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Hadron Therapy Market - North America
- 8.3.1. North America: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.3.2. North America: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.3.3. North America: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.3.4. Hadron Therapy Market - U.S.
- 8.3.4.1. U.S.: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.3.5. Hadron Therapy Market - Canada
- 8.3.5.1. Canada: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.4. Hadron Therapy Market - Europe
- 8.4.1. Europe: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.4.3. Europe: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.4.4. Hadron Therapy Market - UK
- 8.4.4.1. UK: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.4.5. Hadron Therapy Market - France
- 8.4.5.1. France: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.4.5.3. France: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.4.6. Hadron Therapy Market - Germany
- 8.4.6.1. Germany: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.4.7. Hadron Therapy Market - Italy
- 8.4.7.1. Italy: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.4.8. Hadron Therapy Market - Spain
- 8.4.8.1. Spain: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.4.9. Hadron Therapy Market - Netherlands
- 8.4.9.1. Netherlands: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.4.10. Hadron Therapy Market - Russia
- 8.4.10.1. Russia: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.5. Hadron Therapy Market - Asia Pacific
- 8.5.1. Asia Pacific: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.5.4. Hadron Therapy Market - China
- 8.5.4.1. China: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.5.4.3. China: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.5.5. Hadron Therapy Market - India
- 8.5.5.1. India: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.5.5.3. India: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.5.6. Hadron Therapy Market - Malaysia
- 8.5.6.1. Malaysia: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.5.7. Hadron Therapy Market - Japan
- 8.5.7.1. Japan: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.5.8. Hadron Therapy Market - Indonesia
- 8.5.8.1. Indonesia: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.5.9. Hadron Therapy Market - South Korea
- 8.5.9.1. South Korea: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.6. Hadron Therapy Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.6.4. Hadron Therapy Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.6.5. Hadron Therapy Market - UAE
- 8.6.5.1. UAE: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.6.6. Hadron Therapy Market - Israel
- 8.6.6.1. Israel: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.6.7. Hadron Therapy Market - South Africa
- 8.6.7.1. South Africa: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.7. Hadron Therapy Market - Latin America
- 8.7.1. Latin America: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.7.4. Hadron Therapy Market - Mexico
- 8.7.4.1. Mexico: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.7.5. Hadron Therapy Market - Brazil
- 8.7.5.1. Brazil: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
- 8.7.6. Hadron Therapy Market - Argentina
- 8.7.6.1. Argentina: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Advanced Oncotherapy
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. .Danfysik A/S
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Elekta
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Hitachi Ltd
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. IBA Worldwide
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Koninklijke Philips N.V.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Mevion Medical Systems
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Mitsubishi Electric Corporation
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Optivus Proton Therapy Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. ProNova Solutions LLC
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. ProTom International
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Provision Healthcare
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Sumitomo Corporation
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Varian Medical Systems Inc
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
